{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,2]],"date-time":"2026-10-02T13:54:10Z","timestamp":1790949250377,"version":"4.1.0"},"reference-count":41,"publisher":"Spandidos Publications","issue":"3","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2013,3]]},"DOI":"10.3892\/ol.2013.1121","type":"journal-article","created":{"date-parts":[[2013,1,10]],"date-time":"2013-01-10T14:15:36Z","timestamp":1357827336000},"page":"735-738","source":"Crossref","is-referenced-by-count":55,"title":["PAX8 is a novel marker for differentiating between various types of tumor, particularly ovarian epithelial carcinomas"],"prefix":"10.3892","volume":"5","author":[{"given":"LI","family":"XIANG","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"BEIHUA","family":"KONG","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"2249","published-online":{"date-parts":[[2013,1,10]]},"reference":[{"key":"key20180108092500_b1-ol-05-03-0735","doi-asserted-by":"crossref","first-page":"7989","DOI":"10.1038\/sj.onc.1206766","article-title":"Paired-Box genes are frequently expressed in cancer and often required for cancer cell survival","volume":"22","author":"Muratovska","year":"2003","journal-title":"Oncogene"},{"key":"key20180108092500_b2-ol-05-03-0735","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1046\/j.1365-2141.2003.04622.x","article-title":"Possible regulation of Wilms\u2019 tumour gene 1 (WT1) expression by the paired box genes PAX2 and PAX8 and by the haematopoietic transcription factor GATA-1 in human acute myeloid leukaemias","volume":"123","author":"Siehl","year":"2003","journal-title":"Br J Haematol"},{"key":"key20180108092500_b3-ol-05-03-0735","doi-asserted-by":"crossref","first-page":"1566","DOI":"10.1097\/PAS.0b013e31816d71ad","article-title":"Expression of pax8 as a useful marker in distinguishing ovarian carcinomas from mammary carcinomas","volume":"32","author":"Nonaka","year":"2008","journal-title":"Am J Surg Pathol"},{"key":"key20180108092500_b4-ol-05-03-0735","doi-asserted-by":"crossref","first-page":"899","DOI":"10.1111\/j.1432-1033.1995.tb20338.x","article-title":"Distinct functional properties of three human paired-box-protein, PAX8, isoforms generated by alternative splicing in thyroid, kidney and Wilms\u2019 tumors","volume":"228","author":"Poleev","year":"1995","journal-title":"Eur J Biochem"},{"key":"key20180108092500_b5-ol-05-03-0735","doi-asserted-by":"crossref","first-page":"719","DOI":"10.1210\/en.2006-1054","article-title":"Congenital hypothyroid female pax8-deficient mice are infertile despite thyroid hormone replacement therapy","volume":"148","author":"Mittag","year":"2007","journal-title":"Endocrinology"},{"key":"key20180108092500_b6-ol-05-03-0735","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1038\/ng0598-83","article-title":"PAX8 mutations associated with congenital hypothyroidism caused by thyroid dysgenesis","volume":"19","author":"Macchia","year":"1998","journal-title":"Nat Genet"},{"key":"key20180108092500_b7-ol-05-03-0735","doi-asserted-by":"crossref","first-page":"4297","DOI":"10.1002\/j.1460-2075.1996.tb00804.x","article-title":"PAX8-mediated activation of the wt1 tumor suppressor gene","volume":"15","author":"Dehbi","year":"1996","journal-title":"Embo J"},{"key":"key20180108092500_b8-ol-05-03-0735","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1002\/cncy.20136","article-title":"PAX8 is expressed in pancreatic well-differentiated neuroendocrine tumors and in extrapancreatic poorly differentiated neuroendocrine carcinomas in fine-needle aspiration biopsy specimens","volume":"119","author":"Haynes","year":"2011","journal-title":"Cancer Cytopathol"},{"key":"key20180108092500_b9-ol-05-03-0735","doi-asserted-by":"crossref","first-page":"667","DOI":"10.1002\/dc.21590","article-title":"Utility of PAX8 and PAX2 immunohistochemistry in the identification of renal cell carcinoma in diagnostic cytology","volume":"40","author":"Knoepp","year":"2012","journal-title":"Diagn Cytopathol"},{"key":"key20180108092500_b10-ol-05-03-0735","first-page":"3947","article-title":"Expression of PAX8-PPAR gamma 1 rearrangements in both follicular thyroid carcinomas and adenomas","volume":"87","author":"Marques","year":"2002","journal-title":"J Clin Endocrinol Metab"},{"key":"key20180108092500_b11-ol-05-03-0735","doi-asserted-by":"crossref","first-page":"569","DOI":"10.5858\/2010-0664-RAIR.1","article-title":"Molecular diagnostics of thyroid tumors","volume":"135","author":"Nikiforov","year":"2011","journal-title":"Arch Pathol Lab Med"},{"key":"key20180108092500_b12-ol-05-03-0735","doi-asserted-by":"crossref","first-page":"562","DOI":"10.1002\/dc.21426","article-title":"PAX8: A marker for carcinoma of M\u00fcllerian origin in serous effusions","volume":"39","author":"Tong","year":"2011","journal-title":"Diagn Cytopathol"},{"key":"key20180108092500_b13-ol-05-03-0735","doi-asserted-by":"crossref","first-page":"2318","DOI":"10.1210\/jc.2002-021907","article-title":"RAS point mutations and PAX8-PPAR gamma rearrangement in thyroid tumors: evidence for distinct molecular pathways in thyroid follicular carcinoma","volume":"88","author":"Nikiforova","year":"2003","journal-title":"J Clin Endocrinol Metab"},{"key":"key20180108092500_b14-ol-05-03-0735","doi-asserted-by":"crossref","first-page":"192","DOI":"10.1038\/modpathol.3801002","article-title":"Diagnostic utility of thyroid transcription factors Pax8 and TTF-2 (FoxE1) in thyroid epithelial neoplasms","volume":"21","author":"Nonaka","year":"2008","journal-title":"Mod Pathol"},{"key":"key20180108092500_b15-ol-05-03-0735","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1097\/PAI.0b013e3182025f66","article-title":"Expression of PAX8 in normal and neoplastic tissues: a comprehensive immunohistochemical study","volume":"19","author":"Tacha","year":"2011","journal-title":"Appl Immunohistochem Mol Morphol"},{"key":"key20180108092500_b16-ol-05-03-0735","doi-asserted-by":"crossref","first-page":"1357","DOI":"10.1126\/science.289.5483.1357","article-title":"PAX8-PPARgamma 1 fusion in oncogene human thyroid carcinoma","volume":"289","author":"Kroll","year":"2000","journal-title":"Science"},{"key":"key20180108092500_b17-ol-05-03-0735","doi-asserted-by":"crossref","first-page":"1016","DOI":"10.1097\/00000478-200208000-00006","article-title":"PAX8-PPARgamma rearrangement in thyroid tumors: RT-PCR and immunohistochemical analyses","volume":"26","author":"Nikiforova","year":"2002","journal-title":"Am J Surg Pathol"},{"key":"key20180108092500_b18-ol-05-03-0735","first-page":"4666","article-title":"The paired box domain gene PAX5 is fused to ETV6\/TEL in an acute lymphoblastic leukemia case","volume":"61","author":"Cazzaniga","year":"2001","journal-title":"Cancer Res"},{"key":"key20180108092500_b19-ol-05-03-0735","doi-asserted-by":"crossref","first-page":"751","DOI":"10.1038\/modpathol.2011.3","article-title":"PAX 8 expression in non-neoplastic tissues, primary tumors and metastatic tumors: a comprehensive immunohistochemical study","volume":"24","author":"Ozcan","year":"2011","journal-title":"Mod Pathol"},{"key":"key20180108092500_b20-ol-05-03-0735","doi-asserted-by":"crossref","first-page":"965","DOI":"10.1097\/PAS.0b013e3181dc5e8a","article-title":"PAX8 (+)\/p63 (\u2212) immunostaining pattern in renal collecting duct carcinoma (CDC): a useful immunoprofile in the differential diagnosis of CDC versus urothelial carcinoma of upper urinary tract","volume":"34","author":"Albadine","year":"2010","journal-title":"Am J Surg Pathol"},{"key":"key20180108092500_b21-ol-05-03-0735","doi-asserted-by":"crossref","first-page":"723","DOI":"10.1097\/PAS.0b013e3181da0a20","article-title":"PAX8 expression in well-differentiated pancreatic endocrine tumors: correlation with clinicopathologic features and comparison with gastrointestinal and pulmonary carcinoid tumors","volume":"34","author":"Long","year":"2010","journal-title":"Am J Surg Pathol"},{"key":"key20180108092500_b22-ol-05-03-0735","doi-asserted-by":"crossref","first-page":"412","DOI":"10.1038\/modpathol.2010.176","article-title":"PAX8 expression reliably distinguishes pancreatic well-differentiated neuroendocrine tumors from ileal and pulmonary well-differentiated neuroendocrine tumors and pancreatic acinar cell carcinoma","volume":"24","author":"Sangoi","year":"2011","journal-title":"Mod Pathol"},{"key":"key20180108092500_b23-ol-05-03-0735","doi-asserted-by":"crossref","first-page":"1893","DOI":"10.1158\/1055-9965.EPI-10-0437","article-title":"Global patterns of cancer incidence and mortality rates and trends","volume":"19","author":"Jemal","year":"2010","journal-title":"Cancer Epidemiol Biomarkers Prev"},{"key":"key20180108092500_b24-ol-05-03-0735","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1016\/0029-7844(95)00126-C","article-title":"Preoperative CA 125: an independent prognostic factor in patients with stage I epithelial ovarian cancer","volume":"86","author":"Nagele","year":"1995","journal-title":"Obstet Gynecol"},{"key":"key20180108092500_b25-ol-05-03-0735","doi-asserted-by":"crossref","first-page":"476","DOI":"10.1006\/gyno.1999.5621","article-title":"Clinical picture of women with early stage ovarian cancer","volume":"75","author":"Eltabbakh","year":"1999","journal-title":"Gynecol Oncol"},{"key":"key20180108092500_b26-ol-05-03-0735","doi-asserted-by":"crossref","first-page":"4376","DOI":"10.1091\/mbc.E03-05-0279","article-title":"Gene expression patterns in ovarian carcinomas","volume":"14","author":"Schaner","year":"2003","journal-title":"Mol Biol Cell"},{"key":"key20180108092500_b27-ol-05-03-0735","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1016\/j.ygyno.2006.08.052","article-title":"Emerging roles for PAX8 in ovarian cancer and endosalpingeal development","volume":"104","author":"Bowen","year":"2007","journal-title":"Gynecol Oncol"},{"key":"key20180108092500_b28-ol-05-03-0735","doi-asserted-by":"crossref","first-page":"627","DOI":"10.1097\/PAS.0b013e3181da7687","article-title":"PAX8 reliably distinguishes ovarian serous tumors from malignant mesothelioma","volume":"34","author":"Laury","year":"2010","journal-title":"Am J Surg Pathol"},{"key":"key20180108092500_b29-ol-05-03-0735","volume-title":"AJCC Cancer Staging Handbook","author":"Edge","year":"2010","edition":"7th edition"},{"key":"key20180108092500_b30-ol-05-03-0735","doi-asserted-by":"crossref","first-page":"11","DOI":"10.4103\/0970-9371.93210","article-title":"Diagnostic utility of the cell block method versus the conventional smear study in pleural fluid cytology","volume":"29","author":"Shivakumarswamy","year":"2012","journal-title":"J Cytol"},{"key":"key20180108092500_b31-ol-05-03-0735","doi-asserted-by":"crossref","first-page":"454","DOI":"10.1097\/PAP.0b013e318234aaed","article-title":"WT1 expression in the female genital tract","volume":"18","author":"B\u00e1rcena","year":"2011","journal-title":"Adv Anat Pathol"},{"key":"key20180108092500_b32-ol-05-03-0735","doi-asserted-by":"crossref","first-page":"298","DOI":"10.1002\/cncy.20089","article-title":"Utility of paired box gene 8 (PAX8) expression in fluid and fine-needle aspiration cytology: an immunohistochemical study of metastatic ovarian serous carcinoma","volume":"118","author":"McKnight","year":"2010","journal-title":"Cancer Cytopathol"},{"key":"key20180108092500_b33-ol-05-03-0735","doi-asserted-by":"crossref","first-page":"595","DOI":"10.1016\/j.ygyno.2012.08.028","article-title":"Detection of PAX8 and p53 is beneficial in recognizing metastatic carcinomas in pelvic washings, especially in cases with suspicious cytology","volume":"127","author":"Xiang","year":"2012","journal-title":"Gynecol Oncol"},{"key":"key20180108092500_b34-ol-05-03-0735","doi-asserted-by":"crossref","first-page":"995","DOI":"10.1200\/JCO.2006.07.9970","article-title":"Early events in the pathogenesis of epithelial ovarian cancer","volume":"26","author":"Landen","year":"2008","journal-title":"J Clin Oncol"},{"key":"key20180108092500_b35-ol-05-03-0735","first-page":"255","article-title":"Ovarian surface epithelium: biology, endocrinology and pathology","volume":"22","author":"Auersperg","year":"2001","journal-title":"Endocr Rev"},{"key":"key20180108092500_b36-ol-05-03-0735","doi-asserted-by":"crossref","first-page":"230","DOI":"10.1097\/01.pas.0000180854.28831.77","article-title":"The tubal fimbria is a preferred site for early adenocarcinoma in women with familial ovarian cancer syndrome","volume":"30","author":"Medeiros","year":"2006","journal-title":"Am J Surg Pathol"},{"key":"key20180108092500_b37-ol-05-03-0735","doi-asserted-by":"crossref","first-page":"3985","DOI":"10.1200\/JCO.2007.12.2622","article-title":"Primary fallopian tube malignancies in BRCA-positive women undergoing surgery for ovarian cancer risk reduction","volume":"25","author":"Callahan","year":"2007","journal-title":"J Clin Oncol"},{"key":"key20180108092500_b38-ol-05-03-0735","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1097\/01.pgp.0000101082.35393.84","article-title":"Atypical epithelial proliferation in fallopian tubes in prophylactic salpingo-oophorectomy specimens from BRCA1 and BRCA2 germline mutation carriers","volume":"23","author":"Carcangiu","year":"2004","journal-title":"Int J Gynecol Pathol"},{"key":"key20180108092500_b39-ol-05-03-0735","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1016\/j.ygyno.2005.06.065","article-title":"Clinical and pathologic findings of prophylactic salpingo-oophorectomies in 159 BRCA1 and BRCA2 carriers","volume":"100","author":"Finch","year":"2006","journal-title":"Gynecol Oncol"},{"key":"key20180108092500_b40-ol-05-03-0735","doi-asserted-by":"crossref","first-page":"1488","DOI":"10.1038\/modpathol.2011.106","article-title":"Tubal origin of \u2018ovarian\u2019 low-grade serous carcinoma","volume":"24","author":"Li","year":"2011","journal-title":"Mod Pathol"},{"key":"key20180108092500_b41-ol-05-03-0735","doi-asserted-by":"crossref","first-page":"6116","DOI":"10.1158\/1078-0432.CCR-04-2509","article-title":"Patterns of gene expression in different histotypes of epithelial ovarian cancer correlate with those in normal fallopian tube, endometrium and colon","volume":"11","author":"Marquez","year":"2005","journal-title":"Clin Cancer Res"}],"container-title":["Oncology Letters"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/spandidos-publications.com\/10.3892\/ol.2013.1121\/download","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,2,5]],"date-time":"2022-02-05T17:54:35Z","timestamp":1644083675000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.spandidos-publications.com\/10.3892\/ol.2013.1121"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,1,10]]},"references-count":41,"journal-issue":{"issue":"3","published-online":{"date-parts":[[2013,1,10]]},"published-print":{"date-parts":[[2013,3]]}},"alternative-id":["10.3892\/ol.2013.1121"],"URL":"https:\/\/doi.org\/10.3892\/ol.2013.1121","relation":{},"ISSN":["1792-1074","1792-1082"],"issn-type":[{"value":"1792-1074","type":"print"},{"value":"1792-1082","type":"electronic"}],"subject":[],"published":{"date-parts":[[2013,1,10]]}}}